_id
690dafceccc777a4e85d0b2d
Ticker
APLMW
Name
Apollomics Inc. Warrant
Exchange
NASDAQ
Address
-
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Last Close
0.013
Volume
2228
Current Price
0.0145
Change
-0.0003
Last Updated
2026-01-20T15:31:39.099Z
Image
-
Ipo Date
2021-11-26T00:00:00.000Z
Market Cap
40421184
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
8500000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
19108000
Operating Income
-10608000
Interest Expense
35000
Pretax Income
-12535000
Net Income
-12536000
Eps
-11.365367180417044
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
1000
EBITDA
-12500000
Operating Margin
-124.8
Total Other Income Expense Net
-1927000
Cash
2093999
Short Term Investments
-
Receivables
7200000
Inventories
-
Total Current Assets
10129000
Property Plant Equipment
680000
Total Assets
11119000
Payables
-
Short Term Debt
203000
Long Term Debt
-
Total Liabilities
15517000
Equity
-4398000
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-0.0036365393360618466
ROE
285.0386539336062
ROA
-112.74395179422609
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
0.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8500000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
19108000
Quarters > 0 > income Statement > operating Income
-10608000
Quarters > 0 > income Statement > interest Expense
35000
Quarters > 0 > income Statement > pretax Income
-12535000
Quarters > 0 > income Statement > net Income
-12536000
Quarters > 0 > income Statement > eps
-11.365367180417044
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1103000
Quarters > 0 > income Statement > income Tax Expense
1000
Quarters > 0 > income Statement > EBITDA
-12500000
Quarters > 0 > income Statement > operating Margin
-124.8
Quarters > 0 > income Statement > total Other Income Expense Net
-1927000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2093999
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7200000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
10129000
Quarters > 0 > balance Sheet > property Plant Equipment
680000
Quarters > 0 > balance Sheet > total Assets
11119000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
203000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15517000
Quarters > 0 > balance Sheet > equity
-4398000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-11.365367180417044
Quarters > 0 > ratios > PB
-0.0036365393360618466
Quarters > 0 > ratios > ROE
285.0386539336062
Quarters > 0 > ratios > ROA
-112.74395179422609
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-785000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-785000
Quarters > 1 > income Statement > operating Expenses
7627500
Quarters > 1 > income Statement > operating Income
-8412500
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-9196500
Quarters > 1 > income Statement > net Income
-9326000
Quarters > 1 > income Statement > eps
-8.458189733357518
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1102600
Quarters > 1 > income Statement > income Tax Expense
129500
Quarters > 1 > income Statement > EBITDA
-7889500
Quarters > 1 > income Statement > operating Margin
1071.656050955414
Quarters > 1 > income Statement > total Other Income Expense Net
-784000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
9766000
Quarters > 1 > balance Sheet > short Term Investments
14000
Quarters > 1 > balance Sheet > receivables
127000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10267000
Quarters > 1 > balance Sheet > property Plant Equipment
1019000
Quarters > 1 > balance Sheet > total Assets
13098000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
233000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8234000
Quarters > 1 > balance Sheet > equity
4864000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-18652000
Quarters > 1 > cash Flow > depreciation
162000
Quarters > 1 > cash Flow > change In Working Capital
664000
Quarters > 1 > cash Flow > cash From Operations
-12755000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
236000
Quarters > 1 > cash Flow > cash From Financing
-3652000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-8.458189733357518
Quarters > 1 > ratios > PB
0.0032869449013157898
Quarters > 1 > ratios > ROE
-191.73519736842107
Quarters > 1 > ratios > ROA
-71.20171018476104
Quarters > 1 > ratios > FCF
-12755000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
16.248407643312103
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-1570000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-1570000
Quarters > 2 > income Statement > operating Expenses
15255000
Quarters > 2 > income Statement > operating Income
-16825000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-18393000
Quarters > 2 > income Statement > net Income
-18652000
Quarters > 2 > income Statement > eps
-16.916379466715036
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1102600
Quarters > 2 > income Statement > income Tax Expense
259000
Quarters > 2 > income Statement > EBITDA
-15779000
Quarters > 2 > income Statement > operating Margin
1071.656050955414
Quarters > 2 > income Statement > total Other Income Expense Net
-1568000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
9766000
Quarters > 2 > balance Sheet > short Term Investments
14000
Quarters > 2 > balance Sheet > receivables
127000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
10267000
Quarters > 2 > balance Sheet > property Plant Equipment
1019000
Quarters > 2 > balance Sheet > total Assets
13098000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
233000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8234000
Quarters > 2 > balance Sheet > equity
4864000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-18652000
Quarters > 2 > cash Flow > depreciation
162000
Quarters > 2 > cash Flow > change In Working Capital
664000
Quarters > 2 > cash Flow > cash From Operations
-12755000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
236000
Quarters > 2 > cash Flow > cash From Financing
-3652000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-16.916379466715036
Quarters > 2 > ratios > PB
0.0032869449013157898
Quarters > 2 > ratios > ROE
-383.47039473684214
Quarters > 2 > ratios > ROA
-142.40342036952208
Quarters > 2 > ratios > FCF
-12755000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
8.124203821656051
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
-785000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-785000
Quarters > 3 > income Statement > operating Expenses
7627500
Quarters > 3 > income Statement > operating Income
-8412500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9196500
Quarters > 3 > income Statement > net Income
-9326000
Quarters > 3 > income Statement > eps
-8.458189733357518
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1102600
Quarters > 3 > income Statement > income Tax Expense
129500
Quarters > 3 > income Statement > EBITDA
-7889500
Quarters > 3 > income Statement > operating Margin
1071.656050955414
Quarters > 3 > income Statement > total Other Income Expense Net
-784000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
9766000
Quarters > 3 > balance Sheet > short Term Investments
14000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
10267000
Quarters > 3 > balance Sheet > property Plant Equipment
1018999
Quarters > 3 > balance Sheet > total Assets
13098000
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
233000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8234000
Quarters > 3 > balance Sheet > equity
4864000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-9326000
Quarters > 3 > cash Flow > depreciation
81000
Quarters > 3 > cash Flow > change In Working Capital
332000
Quarters > 3 > cash Flow > cash From Operations
-6377500
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
118000
Quarters > 3 > cash Flow > cash From Financing
-1826000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-8.458189733357518
Quarters > 3 > ratios > PB
0.0032869449013157898
Quarters > 3 > ratios > ROE
-191.73519736842107
Quarters > 3 > ratios > ROA
-71.20171018476104
Quarters > 3 > ratios > FCF
-6377500
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
8.124203821656051
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
198000
Annuals > 0 > income Statement > cost Of Revenue
361000
Annuals > 0 > income Statement > gross Profit
198000
Annuals > 0 > income Statement > operating Expenses
42334000
Annuals > 0 > income Statement > operating Income
-42136000
Annuals > 0 > income Statement > interest Expense
179000
Annuals > 0 > income Statement > pretax Income
-53599000
Annuals > 0 > income Statement > net Income
-53858000
Annuals > 0 > income Statement > eps
-58.132230370199274
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
926474
Annuals > 0 > income Statement > income Tax Expense
259000
Annuals > 0 > income Statement > EBITDA
-41055000
Annuals > 0 > income Statement > operating Margin
-21280.80808080808
Annuals > 0 > income Statement > total Other Income Expense Net
-11463000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9766000
Annuals > 0 > balance Sheet > short Term Investments
14000
Annuals > 0 > balance Sheet > receivables
127000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10267000
Annuals > 0 > balance Sheet > property Plant Equipment
1019000
Annuals > 0 > balance Sheet > total Assets
13098000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
233000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8234000
Annuals > 0 > balance Sheet > equity
4864000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-53858000
Annuals > 0 > cash Flow > depreciation
361000
Annuals > 0 > cash Flow > change In Working Capital
1608000
Annuals > 0 > cash Flow > cash From Operations
-28743000
Annuals > 0 > cash Flow > capital Expenditures
24000
Annuals > 0 > cash Flow > cash From Investing
5983000
Annuals > 0 > cash Flow > cash From Financing
468000
Annuals > 0 > cash Flow > net Change In Cash
-22289999
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-58.132230370199274
Annuals > 0 > ratios > PB
0.002761898231907895
Annuals > 0 > ratios > ROE
-1107.2779605263158
Annuals > 0 > ratios > ROA
-411.19254848068414
Annuals > 0 > ratios > FCF
-28767000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-145.28787878787878
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
821000
Annuals > 1 > income Statement > cost Of Revenue
694000
Annuals > 1 > income Statement > gross Profit
821000
Annuals > 1 > income Statement > operating Expenses
54834000
Annuals > 1 > income Statement > operating Income
-54013000
Annuals > 1 > income Statement > interest Expense
150000
Annuals > 1 > income Statement > pretax Income
-172591000
Annuals > 1 > income Statement > net Income
-172601000
Annuals > 1 > income Statement > eps
-231.99994623439116
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
743970
Annuals > 1 > income Statement > income Tax Expense
10000
Annuals > 1 > income Statement > EBITDA
-53446000
Annuals > 1 > income Statement > operating Margin
-6578.928136419002
Annuals > 1 > income Statement > total Other Income Expense Net
-118578000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
32056000
Annuals > 1 > balance Sheet > short Term Investments
5761000
Annuals > 1 > balance Sheet > receivables
466000
Annuals > 1 > balance Sheet > inventories
-466000
Annuals > 1 > balance Sheet > total Current Assets
39925000
Annuals > 1 > balance Sheet > property Plant Equipment
586000
Annuals > 1 > balance Sheet > total Assets
55387000
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
4394000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
14153000
Annuals > 1 > balance Sheet > equity
41234000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-172601000
Annuals > 1 > cash Flow > depreciation
669000
Annuals > 1 > cash Flow > change In Working Capital
-932000
Annuals > 1 > cash Flow > cash From Operations
-43209000
Annuals > 1 > cash Flow > capital Expenditures
6000
Annuals > 1 > cash Flow > cash From Investing
21365000
Annuals > 1 > cash Flow > cash From Financing
21225000
Annuals > 1 > cash Flow > net Change In Cash
-619000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-231.99994623439116
Annuals > 1 > ratios > PB
0.00026161820342435855
Annuals > 1 > ratios > ROE
-418.5890284716496
Annuals > 1 > ratios > ROA
-311.6272771589001
Annuals > 1 > ratios > FCF
-43215000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-52.63702801461632
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
323000
Annuals > 2 > income Statement > cost Of Revenue
775000
Annuals > 2 > income Statement > gross Profit
323000
Annuals > 2 > income Statement > operating Expenses
45404000
Annuals > 2 > income Statement > operating Income
-45081000
Annuals > 2 > income Statement > interest Expense
93000
Annuals > 2 > income Statement > pretax Income
-240810000
Annuals > 2 > income Statement > net Income
-240811000
Annuals > 2 > income Statement > eps
-277.4454524297259
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
867958
Annuals > 2 > income Statement > income Tax Expense
1000
Annuals > 2 > income Statement > EBITDA
-43883000
Annuals > 2 > income Statement > operating Margin
-13956.965944272446
Annuals > 2 > income Statement > total Other Income Expense Net
-195729000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
32675000
Annuals > 2 > balance Sheet > short Term Investments
21939000
Annuals > 2 > balance Sheet > receivables
547000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
55790000
Annuals > 2 > balance Sheet > property Plant Equipment
1476000
Annuals > 2 > balance Sheet > total Assets
76475000
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
614000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
524595000
Annuals > 2 > balance Sheet > equity
-448120000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-240811000
Annuals > 2 > cash Flow > depreciation
775000
Annuals > 2 > cash Flow > change In Working Capital
3651000
Annuals > 2 > cash Flow > cash From Operations
-42824000
Annuals > 2 > cash Flow > capital Expenditures
367000
Annuals > 2 > cash Flow > cash From Investing
29053000
Annuals > 2 > cash Flow > cash From Financing
-294000
Annuals > 2 > cash Flow > net Change In Cash
-14065000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-277.4454524297259
Annuals > 2 > ratios > PB
-0.000028084867892528787
Annuals > 2 > ratios > ROE
53.738061233598145
Annuals > 2 > ratios > ROA
-314.888525661981
Annuals > 2 > ratios > FCF
-43191000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-133.71826625386996
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2000
Annuals > 3 > income Statement > cost Of Revenue
681000
Annuals > 3 > income Statement > gross Profit
2000
Annuals > 3 > income Statement > operating Expenses
50859000
Annuals > 3 > income Statement > operating Income
-50857000
Annuals > 3 > income Statement > interest Expense
83000
Annuals > 3 > income Statement > pretax Income
-94796000
Annuals > 3 > income Statement > net Income
-94797000
Annuals > 3 > income Statement > eps
-109.21841840273377
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
867958
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-50117000
Annuals > 3 > income Statement > operating Margin
-2542850
Annuals > 3 > income Statement > total Other Income Expense Net
-43939000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
46740000
Annuals > 3 > balance Sheet > short Term Investments
47744000
Annuals > 3 > balance Sheet > receivables
506000
Annuals > 3 > balance Sheet > inventories
2255000
Annuals > 3 > balance Sheet > total Current Assets
99368000
Annuals > 3 > balance Sheet > property Plant Equipment
1316000
Annuals > 3 > balance Sheet > total Assets
123437000
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
2663000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
336299000
Annuals > 3 > balance Sheet > equity
-212862000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-94797000
Annuals > 3 > cash Flow > depreciation
681000
Annuals > 3 > cash Flow > change In Working Capital
-453000
Annuals > 3 > cash Flow > cash From Operations
-43312000
Annuals > 3 > cash Flow > capital Expenditures
50000
Annuals > 3 > cash Flow > cash From Investing
-38950000
Annuals > 3 > cash Flow > cash From Financing
-1643000
Annuals > 3 > cash Flow > net Change In Cash
-83905000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-109.21841840273377
Annuals > 3 > ratios > PB
-0.00005912464883351655
Annuals > 3 > ratios > ROE
44.53448713250839
Annuals > 3 > ratios > ROA
-76.79788070027625
Annuals > 3 > ratios > FCF
-43362000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-21681
Annuals > 3 > health Score
30
Valuation > metrics > PE
-11.365367180417044
Valuation > metrics > PB
-0.0036365393360618466
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
285.0386539336062
Profitability > metrics > ROA
-123.76345147596011
Profitability > metrics > Net Margin
-1.4748235294117646
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-303.0857142857143
Risk > final Score
-1182
Risk > verdict
High
Liquidity > metrics > Current Ratio
49.89655172413793
Liquidity > metrics > Quick Ratio
49.89655172413793
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
30
Prev Profitabilities > 1
30
Prev Profitabilities > 2
30
Prev Risks > 0
4
Prev Risks > 1
4
Prev Risks > 2
4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:24:01.472Z
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan APLMW ride the EV wave - Breakout Stock Watch & Stay Ahead With Daily Market Discussions bollywoodhelpline.com
Read more →Bullish Pattern Emerging on ARC Finance Ltd (540135) - July 2025 Review & Free High Return Stock Watch Alerts bollywoodhelpline.com
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Apollomics Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.